SEC Form 4 · accession 0001161697-15-000476
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M Douglas Winship
Officer — VP, Regulatory Operations
Period of report
Nov 4, 2015
Accepted (ET)
Nov 5, 2015 · 11:26 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share | Nov 4, 2015 | M | 60,000 | $1.09 | D | 134,131 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stockF1 | $1.09 | Nov 4, 2015 | M | 60,000 | D | — | Nov 5, 2015 | Common Stock | 60,000 | 237,500 | D |
Explanation of responses
- F1The option was granted on November 5, 2010 and vested in three equal annual installments.